Clover Health Investments, Corp.
CLOV
$3.66
$0.205.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 79.84% | 59.76% | 52.63% | 52.50% | 37.17% |
| Total Depreciation and Amortization | -46.95% | 94.27% | 105.58% | 408.58% | 139.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.66% | -112.93% | -99.20% | -90.79% | 13.27% |
| Change in Net Operating Assets | -49.17% | 66.12% | -188.46% | -149.82% | 59.12% |
| Cash from Operations | 124.09% | 22.96% | -255.90% | -31.60% | 49.48% |
| Capital Expenditure | -166.44% | 79.32% | 82.68% | 82.94% | 86.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.49% | -3.66% | 17.08% | 56.09% | 21.15% |
| Cash from Investing | -99.60% | 24.14% | 68.66% | 102.06% | 47.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.57% | -80.43% | -96.61% | -84.25% | -17.86% |
| Repurchase of Common Stock | -193.62% | -126.13% | -152.84% | -93.74% | 2.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -242.43% | -115.40% | -111.63% | -107.78% | -106.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 285.71% | -104.94% | -301.99% | -11,966.23% | 91.46% |
